Adicet Bio, Inc. (ACET) Analyst Estimates Annual

Adicet Bio, Inc.

ACET (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2029 12-31	2028 12-31	2027 12-31	2026 12-31	2025 12-31	2024 12-31	2023 12-31	2022 12-30	2021 12-30	2020 12-30
Number of Analysts	5	6	6	7	5	6	7	1	2	2
Estimated Revenue
Low	128.9	84.46	42.78	2.86	2.86	1.67	0.556	35.4	8.18	12.5
Average	128.9	84.46	42.78	2.86	2.86	1.67	0.556	35.4	8.18	12.5
High	128.9	84.46	42.78	2.86	2.86	1.67	0.556	35.4	8.18	12.5
Estimated EBITDA
Low	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
Average	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
High	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
Estimated EBIT
Low	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
Average	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
High	-25.78	-16.89	-8.56	-0.571	-0.571	-0.333	-0.111	-7.08	-1.64	-2.5
Estimated Net Income
Low	-78.7	-330.4	-315.7	-219.7	-75.32	-140.7	-290.7	-111.2	-168.1	-312.8
Average	-78.7	-93.72	-103.5	-185.2	-75.32	-139.2	-290.7	-111.2	-168.1	-312.8
High	-78.7	168.5	17.29	-150.7	-75.32	-137.7	-290.7	-111.2	-168.1	-312.8
Estimated SGA Expenses
Low	170.3	111.6	56.53	3.78	3.78	2.2	0.734	46.77	10.82	16.51
Average	170.3	111.6	56.53	3.78	3.78	2.2	0.734	46.77	10.82	16.51
High	170.3	111.6	56.53	3.78	3.78	2.2	0.734	46.77	10.82	16.51
Estimated EPS
Low	-14.33	-60.17	-57.48	-40.01	-13.71	-25.62	-3.31	-1.27	-1.91	-3.56
Average	-14.33	-21.37	-27.87	-33.73	-13.71	-25.44	-3.31	-1.27	-1.91	-3.56
High	-14.33	30.68	3.15	-27.45	-13.71	-25.07	-3.31	-1.27	-1.91	-3.56

Market is Open